| First Author | Kobayashi T | Year | 2014 |
| Journal | Am J Pathol | Volume | 184 |
| Issue | 11 | Pages | 3120-9 |
| PubMed ID | 25173132 | Mgi Jnum | J:216387 |
| Mgi Id | MGI:5608741 | Doi | 10.1016/j.ajpath.2014.07.003 |
| Citation | Kobayashi T, et al. (2014) B Cells Promote Tumor Immunity against B16F10 Melanoma. Am J Pathol 184(11):3120-9 |
| abstractText | B cells are known to be critical mediators of tumor immunity; however, the mechanisms through which they exert this function remain unclear. B-cell linker protein (BLNK) is an essential component of the B-cell antigen receptor signaling machinery and is required for B-cell development, as evidenced by BLNK-deficient (BLNK(-/-)) mice, in which the development and function of B cells are severely impaired. Herein, we evaluated the role of B cells in the development of tumor immunity against B16F10 melanoma using BLNK(-/-) mice. B16F10 melanoma grew more aggressively in BLNK(-/-) mice, resulting in a twofold increase in tumor volume compared with wild-type mice. As predicted, tumor-infiltrating B-cell numbers were decreased in BLNK(-/-) mice. Paradoxically, tumor-infiltrating T-cell numbers were decreased in BLNK(-/-) mice, although inguinal lymph node T-cell numbers were increased. Adoptive transfer of B cells from wild-type mice into BLNK(-/-) mice attenuated B16F10 melanoma growth, with increasing numbers of B and T cells infiltrating into tumors. In addition, percentages of interferon-gamma- and tumor necrosis factor-alpha-producing tumor-infiltrating T cells were restored. Taken together, our study supports the concept that B cells enhance tumor immunity against B16F10 melanoma by promoting T-cell infiltration into tumors and cytokine production within the tumor microenvironment. |
